Investors Sell Shares of UnitedHealth Group (UNH) on Strength on Insider Selling
Investors sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading on Thursday after an insider sold shares in the company. $207.87 million flowed into the stock on the tick-up and $290.47 million flowed out of the stock on the tick-down, for a money net flow of $82.60 million out of the stock. Of all stocks tracked, UnitedHealth Group had the 14th highest net out-flow for the day. UnitedHealth Group traded up $1.02 for the day and closed at $253.27Specifically, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, January 17th. The stock was sold at an average price of $260.55, for a total value of $3,908,250.00. Following the sale, the director now directly owns 193,872 shares in the company, valued at $50,513,349.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, January 22nd. The shares were sold at an average price of $266.61, for a total value of $1,333,050.00. Following the completion of the sale, the director now owns 77,702 shares in the company, valued at $20,716,130.22. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 25,000 shares of company stock worth $6,466,350. Company insiders own 0.87% of the company’s stock.
A number of research firms recently weighed in on UNH. Cantor Fitzgerald restated a “buy” rating and issued a $310.00 price target on shares of UnitedHealth Group in a research note on Wednesday, November 21st. Stephens began coverage on UnitedHealth Group in a research report on Monday, January 14th. They set an “overweight” rating and a $287.00 target price on the stock. Piper Jaffray Companies boosted their target price on UnitedHealth Group to $312.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 28th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, February 27th. Finally, Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $279.00 target price on the stock in a research report on Saturday, January 5th. Two investment analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and a consensus target price of $297.80.
The stock has a market capitalization of $235.93 billion, a P/E ratio of 19.66, a price-to-earnings-growth ratio of 1.26 and a beta of 0.79. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.73 and a quick ratio of 0.73.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th will be issued a $0.90 dividend. The ex-dividend date is Friday, March 8th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is 27.95%.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Crewe Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $25,000. Pearl River Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $35,000. Ipswich Investment Management Co. Inc. acquired a new position in UnitedHealth Group in the fourth quarter valued at $40,000. OLD Second National Bank of Aurora increased its stake in UnitedHealth Group by 70.0% in the fourth quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock valued at $42,000 after purchasing an additional 70 shares during the last quarter. Finally, Laurel Wealth Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $42,000. 85.80% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This story was first reported by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.watchlistnews.com/investors-sell-shares-of-unitedhealth-group-unh-on-strength-on-insider-selling/2890721.html.
UnitedHealth Group Company Profile (NYSE:UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: How prevalent are 12b-1 fees?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.